EyePoint Pharmaceuticals' Duravyu shows promising Phase 2 results in DME, with potential for less frequent dosing. Check out ...

The market is projected to grow at a compound annual growth rate (CAGR) of approximately 6.4% from 2025 to 2035, increasing from USD 18466.9 Million in 2025 to USD 34340.7 Million by 2035.

Age-related macular degeneration (AMD) is a major cause of blindness, especially in older adults. A key feature of early AMD ...

GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with ...

From basal laminar deposits to foveal centering, a new framework refines what clinicians see—and what they treat—in outer retinal disease, as presented at the 2025 International SPECTRALIS Symposium – ...

Recently, to my surprise, I came down with bladder cancer. I am a healthy 66-year-old man who is 5 feet, 11 inches tall, 215 ...

A plant-based but not fully vegetarian diet could boost the health of retinal ganglion cells, potentially mitigating early ...

Jay Chhablani, MD, explains how 3D choroidal vessel segmentation transforms ophthalmology, enhancing disease diagnosis and treatment through advanced imaging technology.

Does Medicare cover annual physical exams? I’ve gotten a physical every year since I turned 50 and would like to find out ...

Disorganization of retinal inner layers (DRIL) is likely an important biomarker signaling visual deterioration in patients with diabetic macular ischemia (DMI), and overall causes for functional ...

Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.